Is hemolysis a novel therapeutic target in COVID-19?

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Article number956671
JournalFrontiers in immunology
Volume13
DOIs
Publication statusPublished - Aug 19 2022

Keywords

  • CD163
  • COVID-19
  • dexamethasone
  • free hemoglobin
  • haptoglobin
  • hemolysis
  • hemopexin
  • sepsis

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this